Max Healthcare Institute Limited has informed the Exchange about Capacity addition
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Max Healthcare reported strong Q1 FY26 (quarter ended June 30, 2025) consolidated results with revenue from operations at ₹2,02,757 lakhs, up about 31% year-on-year from ₹1,54,295 lakhs in Q1 FY25. Consolidated profit after tax rose roughly 30% YoY to ₹30,797 lakhs (vs ₹23,627 lakhs), with basic EPS at ₹3.17 (vs ₹2.43). Standalone revenue grew about 12% YoY to ₹69,402 lakhs and PAT grew about 8% to ₹16,603 lakhs. The Board also approved an Agreement to Lease with Goyal Agrim Infra Realty LLP to set up a ~130 bedded built-to-suit hospital in Dehradun, expected to be commissioned by 2028, with investment of ₹170–200 crore funded mainly through internal accruals. Network capacity currently stands at ~5,200 beds operating at over 76% utilization, and the new Dehradun hospital will focus on advanced oncology services.
Strong double-digit revenue and profit growth signals robust operational momentum and likely positive sentiment, while the Dehradun expansion adds future bed capacity in a high-utilization market and supports long-term growth. Shareholders benefit from continued earnings expansion and a clear capex roadmap, though the new hospital will only contribute from 2028 onwards.